| Technology |
NT ultrasound + two blood hormone markers (Free Beta-hCG and PAPP-A) |
Direct analysis of cell-free fetal DNA from mother’s blood |
| What It Measures |
Indirect risk markers (hormone levels and ultrasound measurement) |
Baby’s actual DNA fragments circulating in mother’s bloodstream |
| Down Syndrome Detection Rate |
Approximately 85 to 90% |
Over 99% |
| Result Type |
Risk score (for example, 1 in 1,500) |
High risk or low risk based on direct DNA analysis |
| Earliest Gestational Age |
11 weeks (must be done by 13 weeks 6 days) |
From 10 weeks onwards |
| Conditions Screened |
Trisomy 21, 18, and 13 |
Trisomy conditions, sex chromosome abnormalities, microdeletions, and more |
| Gender Identification |
Not available |
Available |
| Includes Ultrasound |
Yes, NT scan included |
Not included in test (can be arranged separately) |